Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
1209 results found
2023 ∙ Chen, S. Wei, W. Huang, F. Wang, J. Li, X. Gen, Z. Gao, F. Dong, T. Wei, P. Yang, X. Miao, F.
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
  • Vaccine/vaccination
  • Safety
  • Efficacy/effectiveness
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Mohammed, H. Pham-Tran, D. D. Yeoh, Z. Y. M. Wang, B. McMillan, M. Andraweera, P. H. Marshall, H. S.
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
  • Vaccine/vaccination
  • Efficacy/effectiveness
  • All age groups
  • Healthcare workers
  • COVID-19
Rating:
Critically low
2023 ∙ Whitehead, H. S. French, C. E. Caldwell, D. M. Letley, L. Mounier-Jack, S.
A systematic review of communication interventions for countering vaccine misinformation
  • Vaccine/vaccination
  • Acceptance
  • All age groups
  • Parents/caregivers
  • COVID-19
Rating:
Not applicable
2023 ∙ Jagne, Isatou von Mollendorf, Claire Wee-Hee, Ashleigh Ortika, Belinda Satzke, Catherine Russell, Fiona M.
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Pneumococcal disease
Rating:
Low
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Economic aspects
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
Rating:
Not applicable
2023 ∙ Dadari, I. Belt, R. V. Iyengar, A. Ray, A. Hossain, I. Ali, D. Danielsson, N. Sodha, S. V.
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization
  • Coverage
  • Ethical issues
  • Newborn
  • Children
  • Adolescents
Rating:
Not applicable
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
  • Vaccine/vaccination
  • Safety
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Chen, I. L. Chiu, H. Y.
Association of Herpes zoster with COVID-19 vaccination: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • Safety
  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
Rating:
Critically low
2023 ∙ Hinterseher, J. Hertl, M. Didona, D.
Autoimmune skin disorders and SARS-CoV-2 vaccination – a meta-analysis
  • Vaccine/vaccination
  • Safety
  • All age groups
  • COVID-19
Rating:
Critically low
2023 ∙ Ponjoan, A. Jacques-Aviñó, C. Medina-Perucha, L. Romero, V. Martí-Lluch, R. Alves-Cabratosa, L. Ramos, R. Berenguera, A. Garcia-Gil, M. D. M.
Axes of social inequities in COVID-19 clinical trials: A systematic review
  • Ethical issues
  • Vaccine/vaccination
  • All age groups
  • COVID-19
Rating:
Not applicable